"MASLD has a prevalence of ~30% (range 10-46%) in the U.S. 2 and a prevalence worldwide of ~ 20% (range 6-35%) 3. Metabolic-associated steatohepatitis has a prevalence of 3-5% 3. It is common in children, with a prevalence of 10% 5. It is more commonly seen at ages 40-60 ref. No gender predominance has been noted ref."
"MASLD has a prevalence of ~30% (range 10-46%) in the U.S. 2 and a prevalence worldwide of ~ 20% (range 6-35%) 3. Metabolic-associated steatohepatitis has a prevalence of 3-5% 3. It is common in children, with a prevalence of 10% 5. It is more commonly seen at ages 40-60 ref. No gender predominance has been noted ref."
"Often asymptomatic, although vague abdominal pain has been reported. Hepatomegaly has been reported in a minority of patients. Elevated liver enzymes (such as AST/ALT) may be present, especially with metabolic-associated steatohepatitis."
"Often asymptomatic, although vague abdominal pain has been reported. Hepatomegaly has been reported in a minority of patients. Elevated liver enzymes (such as AST/ALT) may be present, especially with metabolic-associated steatohepatitis."
"IP/OP: drop in signal intensity in liver on the out-of-phase sequence, compatible with intracellular lipid deposition"